|
ZNF263 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.69070002232053E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78149999974231E-07 |
| Normal-vs-Stage2 |
1.778150E-03 |
| Normal-vs-Stage3 |
6.09829999831391E-08 |
| Normal-vs-Stage4 |
2.69580000000769E-06 |
| Stage1-vs-Stage2 |
5.003000E-01 |
| Stage1-vs-Stage3 |
4.382200E-01 |
| Stage1-vs-Stage4 |
6.732600E-01 |
| Stage2-vs-Stage3 |
2.947600E-01 |
| Stage2-vs-Stage4 |
4.164400E-01 |
| Stage3-vs-Stage4 |
8.750800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2681999944929E-08 |
| Normal-vs-AfricanAmerican |
6.221300E-04 |
| Normal-vs-Asian |
3.99440000000695E-05 |
| Caucasian-vs-AfricanAmerican |
8.672200E-01 |
| Caucasian-vs-Asian |
5.092600E-01 |
| AfricanAmerican-vs-Asian |
8.148600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25520000004986E-06 |
| Normal-vs-Female |
6.91830004395655E-09 |
| Male-vs-Female |
7.665200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.93450000036167E-07 |
| Normal-vs-Age(41-60Yrs) |
3.46990000066327E-08 |
| Normal-vs-Age(61-80Yrs) |
6.83679999946563E-07 |
| Normal-vs-Age(81-100Yrs) |
2.075900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.559200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.202600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.138600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.190800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.981800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.401400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.47000000000086E-05 |
| Classical-VS-Follicular |
3.300400E-01 |
| Classical-VS-Other |
1.871980E-01 |
| Classical-VS-Normal |
1.47269999994926E-06 |
| Tall-VS-Follicular |
2.232400E-02 |
| Tall-VS-Other |
8.119400E-01 |
| Tall-VS-Normal |
3.83270082338072E-11 |
| Follicular-VS-Other |
5.121400E-01 |
| Follicular-VS-Normal |
1.78148999999683E-05 |
| Other-VS-Normal |
1.657280E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.94430000053114E-07 |
| Normal-vs-N1 |
1.16219999957146E-07 |
| N0-vs-N1 |
6.677900E-02 |
|
|
